The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: Involvement of 5HT1A receptors and previous stressful experience
Abstract
The prelimbic medial prefrontal cortex (PL) is an important encephalic structure involved in the expression of emotional states. In a previous study, intra-PL injection of cannabidiol (CBD), a major non-psychotomimetic cannabinoid present in the Cannabis sativa plant, reduced the expression of fear conditioning response. Although its mechanism remains unclear, CBD can facilitate 5HT1A receptor-mediated neurotransmission when injected into several brain structures. This study was aimed at verifying if intra-PL CBD could also induce anxiolytic-like effect in a conceptually distinct animal model, the elevated plus maze (EPM). We also verified if CBD effects in the EPM and contextual fear conditioning test (CFC) depend on 5HT1A receptors and previous stressful experience. CBD induced opposite effects in the CFC and EPM, being anxiolytic and anxiogenic, respectively. Both responses were prevented by WAY100,635, a 5HT1A receptor antagonist. In animals that had been previously (24h) submitted to a stressful event (2h-restraint) CBD caused an anxiolytic, rather than anxiogenic, effect in the EPM. This anxiolytic response was abolished by previous injection of metyrapone, a glucocorticoid synthesis blocker. Moreover, restraint stress increased 5HT1A receptors expression in the dorsal raphe nucleus, an effect that was attenuated by injection of metyrapone before the restraint procedure. Taken together, these results suggest that CBD modulation of anxiety in the PL depend on 5HT1A-mediated neurotransmission and previous stressful experience.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The anxiolytic-like effects produced by CBD injections into the rat infralimbic (Marinho et al., 2015) or prelimbic (Fogaca et al., 2014) cortices, BNST (Gomes et al., 2013; Gomes et al., 2012; Gomes et al., 2011) and dPAG (Campos et al., 2013a) are attenuated by concomitant 5-HT1A-R antagonism.”
From The endocannabinoid system as a target for novel anxiolytic drugs (2017) · cites this paper as Fogaca et al., 2014
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
The Rat Brain in Stereotaxic Coordinates
Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585
Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
Pellow, S., Chopin, P., File, S. E., & Briley, M. (1985) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(85)90031-7 · Cited by 5,822
Bisogno, T., Hanuš, L., PETROCELLIS, L. D., Tchilibon, S., Ponde, D. E., Brandi, I., Moriello, A. S., Davis, J. B., Mechoulam, R., & Marzo, V. D. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704327 · Cited by 1,315
Diorio, D., Viau, V, & Meaney, M. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-09-03839.1993 · Cited by 1,151
The neurobiology and control of anxious states
Millan, M. J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00087-x · Cited by 978
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
Izzo, A. A., Borrelli, F., Capasso, R., Marzo, V. D., & Mechoulam, R. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.07.006 · Cited by 879
Agonistic properties of cannabidiol at 5-HT1a receptors
Russo, E. B., Burnett, A., Hall, B., & Parker, K. K. (2005) · Neurochemical Research · doi:10.1007/s11064-005-6978-1 · Cited by 878
Repeated Stress Induces Dendritic Spine Loss in the Rat Medial Prefrontal Cortex
Radley, J. J., Rocher, A. B., Miller, M., Janssen, W. G. M., Liston, C., Hof, P. R., McEwen, B. S., & Morrison, J. H. (2006) · Cerebral Cortex · doi:10.1093/cercor/bhi104 · Cited by 820
Bergamaschi, M. M., Queiroz, R. H. C., Chagas, M. H. N., de Oliveira, D. C. G., De Martinis, B. S., Kapczinski, F., Quevedo, J., Roesler, R., Schröder, N., Nardi, A. E., et al. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.6 · Cited by 771
Vidal-Gonzalez, I., Vidal-Gonzalez, B., Rauch, S. L., & Quirk, G. J. (2006) · Learning & Memory · doi:10.1101/lm.306106 · Cited by 705
Mechoulam, R., Peters, M., Murillo‐Rodriguez, E., & Hanuš, L. O. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790147 · Cited by 515
Celada, P., Puig, M. V., Casanovas, J. M., Guillazo, G., & Artigas, F. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-24-09917.2001 · Cited by 497
Campos, A. C., Moreira, F. A., Gomes, F. V., Del Bel, E. A., & Guimarães, F. S. (2012) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2011.0389 · Cited by 475
Self-citationCannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action
Zuardi, A. W. (2008) · Revista Brasileira de Psiquiatria · doi:10.1590/s1516-44462008000300015 · Cited by 421
Esposito, G., Scuderi, C., Valenza, M., Togna, G. I., Latina, V., De Filippis, D., Cipriano, M., Carratù, M. R., Iuvone, T., & Steardo, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028668 · Cited by 410
Antianxiety effect of cannabidiol in the elevated plus-maze
Guimarães, F. S., Chiaretti, T. M., Graeff, F. G., & Zuardi, A. W. (1990) · Psychopharmacology · doi:10.1007/bf02244012 · Cited by 379
Self-citationAntidepressant‐like effects of cannabidiol in mice: possible involvement of 5‐HT1Areceptors
Zanelati, T., Biojone, C., Moreira, F., Guimarães, F., & Joca, S. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00521.x · Cited by 366
Self-citationEffects of ipsapirone and cannabidiol on human experimental anxiety
Zuardi, A. W., Cosme, R. A., Graeff, F. G., & Guimarães, F. S. (1993) · Journal of Psychopharmacology · doi:10.1177/026988119300700112 · Cited by 364
Campos, A. C., & Guimarães, F. S. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1168-x · Cited by 364
Self-citationCampos, A. C., Ortega, Z., Palazuelos, J., Fogaça, M. V., Aguiar, D. C., Díaz-Alonso, J., Ortega-Gutiérrez, S., Vázquez-Villa, H., Moreira, F. A., Guzmán, M., et al. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712001502 · Cited by 313
Self-citationRole of the medial prefrontal cortex in coping and resilience
Maier, S. F., & Watkins, L. R. (2010) · Brain Research · doi:10.1016/j.brainres.2010.08.039 · Cited by 292
de Bitencourt, R. M., Pamplona, F. A., & Takahashi, R. N. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.07.001 · Cited by 277
Behavioral control, the medial prefrontal cortex, and resilience
Maier, S. F., Amat, J., Baratta, M. V., Paul, E. D., & Watkins, L. R. (2006) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2006.8.4/smaier · Cited by 238
Jinks, A., & McGregor, I. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00810-x · Cited by 229
Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test
Moreira, F. A., Aguiar, D. C., & Guimarães, F. S. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.06.004 · Cited by 207
Self-citationMechoulam, R., & Gaoni, Y. (1965) · Tetrahedron · doi:10.1016/0040-4020(65)80064-3 · Cited by 197
Resstel, L. B. M., Joca, S. R. L., Moreira, F. A., Corrêa, F. M. A., & Guimarães, F. S. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.05.016 · Cited by 182
Self-citationGomes, F. V., Resstel, L. B. M., & Guimarães, F. S. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2036-z · Cited by 174
Self-citationCampos, A. C., & Guimarães, F. S. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.08.017 · Cited by 172
Self-citationCerqueira, J., Taipa, R. J. F., Uylings, H. B. M., Almeida, O. F. X., & Sousa, N. (2006) · Cerebral Cortex · doi:10.1093/cercor/bhl108 · Cited by 171
Serotonergic regulation of neuronal excitability in the prefrontal cortex
Andrade, R. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.015 · Cited by 167
On disruption of fear memory by reconsolidation blockade: evidence from cannabidiol treatment
Stern, C. A. J., Gazarini, L., Takahashi, R. N., Guimarães, F. S., & Bertoglio, L. J. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.63 · Cited by 156
Self-citationLemos, J. I., Resstel, L. B., & Guimarães, F. S. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.09.045 · Cited by 146
Self-citationCampos, A. C., Ferreira, F. R., & Guimarães, F. S. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.08.012 · Cited by 139
Self-citationLaaris, N., Haj‐Dahmane, S., Hamon, M., & Lanfumey, L. (1995) · Neuropharmacology · doi:10.1016/0028-3908(95)00095-n · Cited by 125
Postsynaptic 5-HT1A receptors control 5-HT release in the rat medial prefrontal cortex
Casanovas, J. M., Hervás, I., & Artigas, F. (1999) · Neuroreport · doi:10.1097/00001756-199905140-00010 · Cited by 118
Soares, V. D. P., Campos, A. C., Bortoli, V. C. D., Zangrossi, H., Guimarães, F. S., & Zuardi, A. W. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.05.004 · Cited by 112
Self-citationSerotonergic activation reduces defensive freezing in the conditioned fear paradigm
Inoue, T. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02084-5 · Cited by 106
Fogaça, M. V., de Aguiar, D. C., Moreira, F. A., & Guimarães, F. S. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.03.007 · Cited by 89
Self-citationMetyrapone pretreatment prevents the behavioral and neurochemical sequelae induced by stress
Calvo, N., Martijena, I. D., Molina, V. A., & Volosin, M. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00515-0 · Cited by 80
Campos, A. C., Ferreira, F. R., Guimarães, F. S., & Lemos, J. I. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.01.062 · Cited by 76
Self-citationThe Formation and Stability of Recognition Memory: What Happens Upon Recall?
Davis, S., Renaudineau, S., Poirier, R., Poucet, B., Save, É., & Laroche, S. (2010) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2010.00177 · Cited by 75
Padovan, C. M., Bel, E. A. D., & Guimarães, F. S. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00361-0 · Cited by 72
Self-citationCampos, A. C., de Paula Soares, V., Carvalho, M. C., Ferreira, F. R., Vicente, M. A., Brandão, M. L., Zuardi, A. W., Zangrossi, H., & Guimarães, F. S. (2013) · Psychopharmacology · doi:10.1007/s00213-012-2878-7 · Cited by 65
Self-citationTreit, D., Robinson, A., Rotzinger, S., & Pesold, C. (1993) · Behavioural Brain Research · doi:10.1016/0166-4328(93)90045-r · Cited by 65
de Visser, L. (2011) · Frontiers in Neuroscience · doi:10.3389/fnins.2011.00102 · Cited by 65
Lisboa, S. F. D. S., Stecchini, M. F., Corrêa, F. M. D. A., Guimarães, F. S., & Resstel, L. B. M. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.09.048 · Cited by 64
Self-citationMiller, M. M., Morrison, J. H., & McEwen, B. S. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.01.029 · Cited by 49
García‐Iglesias, B. B., Mendoza‐Garrido, M. E., Gutiérrez‐Ospina, G., Rangel‐Barajas, C., Noyola-Díaz, M., & Terrón, J. A. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.03.013 · Cited by 47
5HT1A and 5HT1B receptors of medial prefrontal cortex modulate anxiogenic-like behaviors in rats
Solati, J., Salari, A., & Bakhtiari, A. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.09.058 · Cited by 44
Fogaça, M. V., Gomes, F. V., Moreira, F. A., Guimarães, F. S., & de Aguiar, D. C. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2927-2 · Cited by 27
Self-citation
Cited by
Sorted by citations
Cannabidiol as a Potential Treatment for Anxiety Disorders
Blessing, E., Steenkamp, M. M., Manzanares, J., & Marmar, C. R. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0387-1 · Cited by 752
Ligresti, A., PETROCELLIS, L. D., & Marzo, V. D. (2016) · Physiological Reviews · doi:10.1152/physrev.00002.2016 · Cited by 505
“Accordingly, CBD attenuates the acute autonomic responses associated to stress in rats by facilitating 5-HT1A receptor-mediated neurotrasmission (266, 724).”
BackgroundCannabidiol, neuroprotection and neuropsychiatric disorders
Campos, A. C., Fogaça, M. V., Sonego, A. B., & Guimarães, F. S. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.01.033 · Cited by 446
Self-citationMedial prefrontal cortex in neurological diseases
Xu, P., Chen, A., Li, Y., Xing, X., & Lü, H. (2019) · Physiological Genomics · doi:10.1152/physiolgenomics.00006.2019 · Cited by 360
Translational investigation of the therapeutic potential of Cannabidiol (CBD): Toward a new age
Crippa, J. A., Guimarães, F. S., Campos, A. C., & Zuardi, A. W. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02009 · Cited by 308
Self-citation
Metadata
- Authors
- Fogaça, M. V., Reis, F. M. C. V., Campos, A. C., & Guimarães, F. S.
- Affiliations
- Universidade de São Paulo (BR)
- Universidade Federal de Minas Gerais (BR)
- Corresponding author
- Fogaça, M.V.
- Venue
- European Neuropsychopharmacology
- Publisher
- Elsevier BV
- Published
- 2014-03
- Volume
- 24
- Issue
- 3
- Pages
- 410-419
- ISSN
- 0924-977X (ISSN-L)
- OpenAlex
- W1975839888
- Semantic Scholar
- 520a9e101f0113f63d37c6bb694ef23f93512fe6
- Cited by
- 153
- References
- 52
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 12 · 2023: 10 · 2022: 12 · 2021: 24 · 2020: 16 · 2019: 16 · 2018: 10 · 2017: 17 · 2016: 12 · 2015: 9 · 2014: 2
- FWCI
- 5.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plant Extracts Effects
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- cannabidiol, anxiety-like behavior, 5-HT1A receptor, restraint stress, anxiolytic effects, anxiogenic effects, dorsal raphe nucleus, metyrapone, glucocorticoid synthesis, WAY-100635, contextual fear conditioning, elevated plus maze
- MeSH terms
- Animals, Anxiety, Cannabidiol, Conditioning, Psychological, Dose-Response Relationship, Drug, Enzyme Inhibitors, Exploratory Behavior, Fear, Male, Metyrapone, Piperazines, Pyridines, Raphe Nuclei, Restraint, Physical, Stress, Psychological, Time Factors, Anti-Anxiety Agents, Rats, Wistar, Prefrontal Cortex, Maze Learning, Receptor, Serotonin, 5-HT1A, Serotonin 5-HT1 Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review